# Patients Preference for Oral or i.v. Therapy

> **NCT00212589** · PHASE3 · COMPLETED · sponsor: **Odense University Hospital** · enrollment: 60 (—)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** Capecitabine
- **DRUG:** Fluorouracil + folinic acid

## Key facts

- **NCT ID:** NCT00212589
- **Lead sponsor:** Odense University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-12
- **Primary completion:** —
- **Final completion:** 2004-04
- **Target enrollment:** 60 (—)
- **Last updated:** 2005-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00212589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00212589, "Patients Preference for Oral or i.v. Therapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00212589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*